Incyte
INCY
#1201
Rank
S$24.02 B
Marketcap
S$120.72
Share price
-1.42%
Change (1 day)
33.25%
Change (1 year)

Incyte (INCY) - Net assets

Net assets on the balance sheet as of December 2025 : S$6.59 Billion

According to Incyte's latest financial reports the company has S$6.59 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Incyte - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2025-12-31$S$6.63 B41.57%
2024-12-31$S$4.68 B-31.63%
2023-12-31$S$6.85 B16.99%
2022-12-31$S$5.85 B14.95%
2021-12-31$S$5.09 B47.54%
2020-12-31$S$3.45 B-1.39%
2019-12-31$S$3.50 B33.14%
2018-12-31$S$2.63 B20.64%
2017-12-31$S$2.18 B259.25%
2016-12-31$S$0.60 B150.76%
2015-12-31$S$0.24 B-324.46%
2014-12-31$-S$0.11 Billion-55.92%
2013-12-31$-S$0.25 Billion14.35%
2012-12-31$-S$0.22 Billion-27.25%
2011-12-31$-S$0.3 Billion157.55%
2010-12-31$-S$0.12 Billion-20.56%
2009-12-31$-S$0.15 Billion-54.47%
2008-12-31$-S$0.32 Billion37.53%
2007-12-31$-S$0.23 Billion76.3%
2006-12-31$-S$0.14 Billion303.14%
2005-12-31$-S$32.3 Million-125.21%
2004-12-31$S$0.12 B-51.15%
2003-12-31$S$0.26 B-50.03%
2002-12-31$S$0.52 B-35.61%
2001-12-31$S$0.81 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
S$59.36 B 800.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$118.72 B 1,701.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$33.84 B 413.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$12.26 B 86.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$1.21 B-81.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
S$0.31 B-95.19%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-S$32.33 Million-100.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
S$36.78 M-99.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
S$0.19 B-97.01%๐Ÿ‡บ๐Ÿ‡ธ USA